EP1280888A1 - Zellkukturverfahren, zellmassen so hergestellt und ihre verwendung - Google Patents

Zellkukturverfahren, zellmassen so hergestellt und ihre verwendung

Info

Publication number
EP1280888A1
EP1280888A1 EP01927982A EP01927982A EP1280888A1 EP 1280888 A1 EP1280888 A1 EP 1280888A1 EP 01927982 A EP01927982 A EP 01927982A EP 01927982 A EP01927982 A EP 01927982A EP 1280888 A1 EP1280888 A1 EP 1280888A1
Authority
EP
European Patent Office
Prior art keywords
cells
organoids
spheroids
sheets
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01927982A
Other languages
English (en)
French (fr)
Inventor
Alain Othon André MILLER
Nathalie Liliane Paule Ghislaine Ropson-Kenda
Christophe Alexandre Maurice Soler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
La Region Wallonne
Original Assignee
4C Biotech SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 4C Biotech SA filed Critical 4C Biotech SA
Publication of EP1280888A1 publication Critical patent/EP1280888A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068General culture methods using substrates
    • C12N5/0075General culture methods using substrates using microcarriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0676Pancreatic cells
    • C12N5/0677Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0697Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698Skin equivalents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/09Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/13Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323Adult fibroblasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00Use of cells in diagnostics
    • C12N2503/04Screening or testing on artificial tissues
    • C12N2503/06Screening or testing on artificial skin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2539/00Supports and/or coatings for cell culture characterised by properties
    • C12N2539/10Coating allowing for selective detachment of cells, e.g. thermoreactive coating

Definitions

  • the present invention relates to novel methods of culturing anchor-dependent cells on microsupports with two-dimensional cryosensitive geometry. More specifically, the invention relates to methods for obtaining anchored-dependent animal cells, individualized or forming cellular associations of leaf types, aggregates, spheroids or more organized organoids, having particular properties such as high cell viability. and homogeneity in size of the cell clusters.
  • the cell sheets recovered in step a) are preferably homodisperse in size, and the size of the spheroids or organoids obtained is controlled. This size essentially depends on the size of the microcarriers, and on the morphology of the cultured cells.
  • organoids can be produced by a method comprising the following steps: a) obtaining spheroids or organoids by a method as described above, b) inoculating these spheroids or organoids with other

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP01927982A 2000-04-18 2001-04-17 Zellkukturverfahren, zellmassen so hergestellt und ihre verwendung Withdrawn EP1280888A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0005008A FR2807765B1 (fr) 2000-04-18 2000-04-18 Procede de culture de cellules, amas cellulaires obtenus par ces procedes et utilisation de ceux-ci
FR0005008 2000-04-18
PCT/FR2001/001177 WO2001079453A1 (fr) 2000-04-18 2001-04-17 Procedes de culture de cellules, amas cellulaires obtenus par ces procedes et utilisation de ceux-ci

Publications (1)

Publication Number Publication Date
EP1280888A1 true EP1280888A1 (de) 2003-02-05

Family

ID=8849393

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01927982A Withdrawn EP1280888A1 (de) 2000-04-18 2001-04-17 Zellkukturverfahren, zellmassen so hergestellt und ihre verwendung

Country Status (4)

Country Link
EP (1) EP1280888A1 (de)
AU (1) AU2001254864A1 (de)
FR (1) FR2807765B1 (de)
WO (1) WO2001079453A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2657013A1 (en) * 2006-07-06 2008-01-10 Organogenesis Inc. Temperature-responsive microcarrier
FI20065514A0 (fi) * 2006-08-16 2006-08-16 Licentia Oy Aktivoidut fibroblastit kudosvaurioiden hoitamiseksi
US10108980B2 (en) * 2011-06-24 2018-10-23 At&T Intellectual Property I, L.P. Method and apparatus for targeted advertising
FR3027917B1 (fr) * 2014-10-30 2016-12-30 Syntivia Spheroides mixtes de melanocytes et de keratinocytes
CN114410466A (zh) * 2020-04-01 2022-04-29 沈西凌 用于个性化癌症治疗的精确药物筛选

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1095967A1 (de) * 1999-10-29 2001-05-02 Computer Cell Culture Center S.A. Neue Zellkulturträger mit besonderen Eigenschaften und ihre Herstellung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0355112A1 (de) * 1987-04-22 1990-02-28 Michael Bay Zellkulturverfahren, -materialien und -produkte
EP0470681A3 (en) * 1990-08-08 1992-04-22 W.R. Grace & Co.-Conn. Cell clusters or sheets comprising a plurality of cell species and preparations thereof
EP0499932A1 (de) * 1991-02-16 1992-08-26 W.R. Grace & Co.-Conn. Tumorzellmasse, die Tumorzellen und Normalzellen enthält, und ihre Herstellung
JPH06510899A (ja) * 1991-02-18 1994-12-08 コンピューター セル カルチャー センター 細胞の培養のための支持体およびそのような支持体の製造方法
WO1993003139A1 (fr) * 1991-08-08 1993-02-18 Kao Corporation Support pour la culture de cellules, production de ce support et production d'un amas de cellules au moyen de ce support
IL115728A0 (en) * 1994-10-25 1996-01-19 Boehringer Mannheim Gmbh Biomaterial containing epithelial cells and use thereof as a transplant

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1095967A1 (de) * 1999-10-29 2001-05-02 Computer Cell Culture Center S.A. Neue Zellkulturträger mit besonderen Eigenschaften und ihre Herstellung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0179453A1 *

Also Published As

Publication number Publication date
WO2001079453A1 (fr) 2001-10-25
FR2807765A1 (fr) 2001-10-19
FR2807765B1 (fr) 2004-12-31
AU2001254864A1 (en) 2001-10-30

Similar Documents

Publication Publication Date Title
Takahashi et al. Controlled chain length and graft density of thermoresponsive polymer brushes for optimizing cell sheet harvest
TWI288779B (en) Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
CN102858380B (zh) 胰岛细胞片、制造方法及其利用方法
CN1798832B (zh) 含有动物培养细胞球状体的培养细胞构成物及其用途
TWI740180B (zh) 來自肝外樹狀膽管的多潛能幹細胞及其分離方法
JP5407343B2 (ja) 生体組織の作製方法
WO2001019965A1 (fr) Methodes et compositions pour la conservation de chondrocytes et utilisations
TWI374743B (en) Composite for thermo-sensitive cell-tissue transplanted scaffold and use thereof
FR2679250A1 (fr) Utilisation de carbonate de calcium poreux comme materiau support de culture in vitro de cellules eucaryotes.
JP2009213716A (ja) 血管組織形成法
TW201014914A (en) Materials and methods for cell growth
CA3101003A1 (fr) Systeme de culture cellulaire en bioreacteur
FR2810552A1 (fr) Polymere biocompatible a structure tridimensionnelle a cellules communicantes, procede de preparation et application en medecine et en chirurgie
Yajima et al. Collagen microparticle-mediated 3D cell organization: a facile route to bottom-up engineering of thick and porous tissues
Hayashi et al. Construction of hybrid cell spheroids using cell-sized cross-linked nanogel microspheres as an artificial extracellular matrix
JP6426327B2 (ja) 接着状態の細胞培養物の改変方法
TWI285100B (en) Surface modification of polysaccharide, the modified polysaccharide, and method of culturing and recovery cells using the same
EP1280888A1 (de) Zellkukturverfahren, zellmassen so hergestellt und ihre verwendung
Kobayashi et al. Design of temperature-responsive cell culture surfaces for cell sheet-based regenerative therapy and 3D tissue fabrication
AU2004317828B2 (en) Tissue-like organization of cells and macroscopic tissue-like constructs, generated by macromass culture of cells, and the method of macromass culture
EP4499160B9 (de) Verwendung von mikroträgern auf polymerbasis bei der produktion von gewebegerüsten mit komplexer geometrie
Leisi Mehrabani et al. Mechanical harvesting of cell sheets: an efficient approach for bone and cartilage tissue engineering
Sakai et al. In vitro function of porcine hepatocyte spheroids in 100% human plasma
Yeh et al. Self-patterning of adipose-derived mesenchymal stem cells and chondrocytes cocultured on hyaluronan-grafted chitosan surface
JP2014023540A (ja) 生体組織の作製方法

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20021021

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

17Q First examination report despatched

Effective date: 20080118

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: LA REGION WALLONNE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100901